Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Long-Term Deferred Tax (2016 - 2026)

Argenx Se's (ARGX) quarterly Long-Term Deferred Tax came in at $1.4 billion in Q2 2026, down 99.84% on a YoY basis from $899.6 billion in Q2 2025, and up 10.26% quarter-over-quarter from $1.3 billion in Q4 2025.

Analysis

Argenx Se (ARGX) Long-Term Deferred Tax (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Long-Term Deferred Tax for 11 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Long-Term Deferred Tax fell 99.84% year-over-year to $1.4 billion; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (down 99.84% YoY), and the FY2025 full-year result was $1.3 billion, down 99.86% from the prior year.
  • Long-Term Deferred Tax advanced to $1.4 billion in Q2 2026 per ARGX's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $924.3 billion in Q4 2024 and bottomed at $54.3 million in Q2 2022.
  • Historically, Long-Term Deferred Tax has averaged $211.8 billion across 5 years, with a median of $1.3 billion in 2025.
  • The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax tumbled 99.88% in 2023, then jumped 950717.29% in 2024.
  • Over 5 years, Long-Term Deferred Tax stood at $79.2 billion in 2022, then sank by 99.88% to $97.2 million in 2023, then surged by 950717.29% to $924.3 billion in 2024, then slumped by 99.86% to $1.3 billion in 2025, then rose by 10.26% to $1.4 billion in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $1.4 billion, $1.3 billion, and $899.6 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.43 Bn
Dec 31, 2025 1.30 Bn
Jun 30, 2025 899.61 Bn
Dec 31, 2024 924.30 Bn
Jun 30, 2024 174.63 Mn
Dec 31, 2023 97.21 Mn
Jun 30, 2023 138.77 Mn
Dec 31, 2022 79.22 Bn
Jun 30, 2022 54.27 Mn
Dec 31, 2021 32.19 Bn
Jun 30, 2021 16.25 Mn
Dec 31, 2020 14.61 Bn
Dec 31, 2019 44.28 Mn
Dec 31, 2018 33.44 Mn
Dec 31, 2017 33.44 Mn
Dec 31, 2016 22.67 Mn
API Access

Argenx Se Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ARGX&period=max&api_key=YOUR_API_KEY